EISMEA's Pharmaceutical Portfolio

Novel technology for industrial filtration, purification and drying of specialty compounds (Pharma,, Cosmetics, Chemical, Food&Beverage)

Natac is a company dedicated to investigating, developing, and sustainably manufacturing ingredients of natural origin.

TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.

Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Klaria's business concept is to develop and commercialize innovative products

Khondrion is a clinical-stage pharmaceutical company.

AI Healthtech company developing platform to aggregate structured, contextualized data for applied precision medicine and research.

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines and therapeutics into fridge free thermostable products.

Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.

MEDIKURA develops communication software for pharma companies

Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.

Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease

Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.

ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

Allero Therapeutics is a biopharmaceutical company.

Treat your customers as individuals - provide personalized products using our innovative 3D printing solutions. Food. Personal Care. Pharma.

ChemiCare is committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases.

MyBiotics leverages proprietary culturing & AI technologies to develop microbiome-based products for the therapeutics and food markets

Lucine has the ambition to transform and improve patient’s health.

Scandion Oncology develops drugs that specifically target chemotherapy resistance mechanisms.

AFYX Therapeutics is a clinical stage biopharmaceutical company

Leukos Biotech is a biopharmaceutical company

GlyCardial Diagnostics is a spin-off company of the IR-Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council.

Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.